X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20017) 20017
Publication (1743) 1743
Newspaper Article (350) 350
Book Review (298) 298
Newsletter (253) 253
Book Chapter (130) 130
Book / eBook (56) 56
Conference Proceeding (38) 38
Magazine Article (24) 24
Dissertation (15) 15
Web Resource (13) 13
Trade Publication Article (8) 8
Data Set (7) 7
Reference (5) 5
Government Document (2) 2
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10931) 10931
animals (9056) 9056
index medicus (8493) 8493
male (6715) 6715
adenosine (5031) 5031
female (4622) 4622
rats (3225) 3225
pharmacology & pharmacy (2844) 2844
adenosine triphosphate - metabolism (2836) 2836
mice (2732) 2732
middle aged (2522) 2522
proteins (2132) 2132
adult (1990) 1990
research (1990) 1990
research article (1874) 1874
medicine (1838) 1838
aged (1772) 1772
adenosine - therapeutic use (1763) 1763
adenosine triphosphatase (1601) 1601
cardiac & cardiovascular systems (1530) 1530
multidisciplinary sciences (1527) 1527
apoptosis (1508) 1508
kinases (1418) 1418
science (1403) 1403
health aspects (1390) 1390
physiological aspects (1362) 1362
rodents (1362) 1362
metabolism (1333) 1333
cancer (1330) 1330
adenosine triphosphate (1329) 1329
adenosine - analogs & derivatives (1319) 1319
physiology (1314) 1314
neurosciences (1299) 1299
analysis (1294) 1294
cell biology (1286) 1286
biochemistry & molecular biology (1234) 1234
gene expression (1206) 1206
inflammation (1201) 1201
disease models, animal (1196) 1196
care and treatment (1177) 1177
dose-response relationship, drug (1151) 1151
activation (1132) 1132
article (1104) 1104
treatment outcome (1095) 1095
time factors (1089) 1089
inhibition (1082) 1082
atp (1067) 1067
enzymes (1055) 1055
expression (1051) 1051
oxidative stress (1041) 1041
oncology (1038) 1038
platelet aggregation inhibitors - therapeutic use (1038) 1038
signal transduction (1029) 1029
phosphorylation (1023) 1023
rats, sprague-dawley (1010) 1010
biology (1002) 1002
adenosine - pharmacology (977) 977
ischemia (968) 968
immunology (966) 966
studies (929) 929
in vitro techniques (894) 894
biochemistry (882) 882
medicine, research & experimental (851) 851
cells (835) 835
surgery (825) 825
mitochondria (824) 824
hematology (817) 817
rats, wistar (810) 810
platelet aggregation - drug effects (807) 807
cells, cultured (803) 803
pharmacology (795) 795
genetic aspects (770) 770
peripheral vascular disease (747) 747
ticlopidine - analogs & derivatives (745) 745
mutation (743) 743
cell line, tumor (722) 722
receptors (714) 714
drug therapy (699) 699
clopidogrel (691) 691
adenosine triphosphate - therapeutic use (681) 681
risk factors (678) 678
heart (675) 675
adenosine triphosphatases - metabolism (661) 661
myocardium - metabolism (646) 646
ticlopidine - therapeutic use (645) 645
disease (638) 638
review (638) 638
mice, inbred c57bl (637) 637
adenosine diphosphate - pharmacology (632) 632
brain (630) 630
diabetes (623) 623
adenosine triphosphate - pharmacology (618) 618
in-vitro (605) 605
medical research (593) 593
therapy (592) 592
adolescent (581) 581
adenosine - metabolism (573) 573
cell line (568) 568
patients (555) 555
tumors (548) 548
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (31) 31
Online Resources - Online (6) 6
UofT at Mississauga - Stacks (3) 3
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19686) 19686
Russian (329) 329
German (207) 207
Japanese (157) 157
French (111) 111
Italian (105) 105
Chinese (59) 59
Spanish (56) 56
Polish (33) 33
Ukrainian (19) 19
Portuguese (13) 13
Hungarian (11) 11
Czech (10) 10
Romanian (8) 8
Turkish (6) 6
Dutch (5) 5
Slovak (5) 5
Bulgarian (3) 3
Korean (3) 3
Croatian (2) 2
Finnish (2) 2
Hebrew (2) 2
Danish (1) 1
Greek (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, 1. Aufl., Current topics in microbiology and immunology, ISBN 3642282954, Volume 355., x, 234
Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function,... 
Chemotherapy | Antineoplastic Protocols | Cancer | Clinical & internal medicine | Protein kinases | Inhibitors
Book
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 611 - 621
Mortality and morbidity in acute coronary syndromes (ACSs), caused principally by plaque erosion or rupture leading to thrombus formation and myocardial... 
Cardiovascular | WORKING GROUP | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | EUROPEAN-SOCIETY | ELEVATION MYOCARDIAL-INFARCTION | CONSENSUS DOCUMENT | PLATELET REACTIVITY | ATRIAL-FIBRILLATION | UNFRACTIONATED HEPARIN | Recombinant Proteins - therapeutic use | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Hirudins | Humans | Heparin - therapeutic use | Enoxaparin - therapeutic use | Tyrosine - analogs & derivatives | Receptors, Thrombin - antagonists & inhibitors | Warfarin - therapeutic use | Tyrosine - therapeutic use | Adenosine - therapeutic use | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Anticoagulants - therapeutic use | Piperazines - therapeutic use | Adenosine Monophosphate - therapeutic use | Lactones - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Peptide Fragments - therapeutic use | Peptides - therapeutic use | Aspirin | Glycosaminoglycans | Atrial fibrillation | Mortality | Thrombin | Anticoagulants (Medicine) | Health aspects | Drug approval | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Clinical outcomes | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
European Heart Journal, ISSN 0195-668X, 04/2017, Volume 38, Issue 13, pp. 935 - 941d
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations 
CONTROLLED CLINICAL-TRIAL | PROTEIN KINASE-C | PERCUTANEOUS CORONARY INTERVENTION | MITOCHONDRIAL PERMEABILITY TRANSITION | CARDIAC & CARDIOVASCULAR SYSTEMS | NO-REFLOW PHENOMENON | RANDOMIZED CONTROLLED-TRIAL | BYPASS GRAFT-SURGERY | ISCHEMIA-REPERFUSION | LEFT-VENTRICULAR FUNCTION | LONG-TERM BENEFIT | Myocardial Reperfusion Injury - etiology | Nucleotides, Cyclic - metabolism | Ischemic Postconditioning - methods | Vasodilator Agents - therapeutic use | Humans | Oximes - therapeutic use | Nitric Oxide - therapeutic use | Oligopeptides - therapeutic use | Patient Selection | ST Elevation Myocardial Infarction - therapy | Cardiotonic Agents - therapeutic use | Mitochondrial Membrane Transport Proteins - physiology | Adenosine - therapeutic use | Hypothermia, Induced - methods | ST Elevation Myocardial Infarction - complications | ST Elevation Myocardial Infarction - etiology | Coronary Vessels - physiology | Metoprolol - therapeutic use | Combined Modality Therapy | Protein Kinase C - antagonists & inhibitors | Enzyme Inhibitors - therapeutic use | Nitrites - therapeutic use | Cyclosporine - therapeutic use | Myocardial Reperfusion - adverse effects | Signal Transduction - physiology | Clinical Trials as Topic - methods | Nitric Oxide - metabolism | Secosteroids - therapeutic use | Myocardial Reperfusion Injury - prevention & control | Life Sciences | Current Opinion | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Congenital Heart Disease, ISSN 1747-079X, 01/2013, Volume 8, Issue 1, pp. 48 - 56
Objectives.  The current drug of choice for reentrant supraventricular tachycardia (SVT) is adenosine followed by verapamil or diltiazem. Although limitations... 
Cardioversion | Supraventricular Tachycardia | Adenosine | Adrenergic Agonists | Arrhythmias | Dexmedetomidine | Adrenergic agonists | Supraventricular tachycardia | EMERGENCY | TACHYARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | ATRIAL | CONGENITAL CARDIAC-SURGERY | CHILDREN | NUCLEUS | INFANTS | VERAPAMIL | Usage | Cardiac patients | Sympathomimetic agents | Children | Diltiazem | Health aspects
Journal Article
2012, Current topics in microbiology and immunology, ISBN 3642282954, Volume 355
Web Resource
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 24, pp. 2261 - 2273
Journal Article